Diagnosis and antibacterial treatment for community-acquired pneumonia in children during the COVID-19 pandemic
Особенности диагностики и антибактериальной терапии внебольничной пневмонии у детей в период пандемии СОVID-19

S.V. Zaitseva, A.I. Evdokimov Moscow University of Medicine & Dentistry, Moscow, Russian Federation, O.V. Zaitseva, E.E. Lokshina, Federal Research Clinical Center for Children and Adolescents of the Federal Medical Biological Agency of Russia, Moscow, Russian Federation, A.I. Evdokimov Moscow University of Medicine & Dentistry, Moscow, Russian Federation, A.I. Evdokimov Moscow University of Medicine & Dentistry, Moscow, Russian Federation
2021 Russian Journal of Woman and Child Health  
During the COVID-19 pandemic, the reasonable use of antibiotics became an important issue of practical health care. This fact is accounted for by the heavy burden of COVID-19 on healthcare system, difficulties with interpreting respiratory disorders and verifying communityacquired pneumonia using instrumental and laboratory tests. Therefore, the risk of unnecessary prescription of antibiotics and, as a result, the prevalence of antibiotic resistance significantly increase. This paper addresses
more » ... urrent ideas about the role of the most common causative agents of community-acquired pneumonia in children, the milestones of the diagnosis of community-acquired pneumonia, differential diagnosis of viral and bacterial pneumonia, the algorithms of the choice of basic antibacterial treatment in out-patient settings. The authors emphasize that only the use of limited antibiotic spectrum (i.e., amoxicillin, inhibitor-protected aminopenicillins), their rational dosing and course treatment recommended for community-acquired pneumonia will prevent the loss of antibacterial efficacy for infectious diseases. KEYWORDS: community-acquired pneumonia, children, SARS-CoV-2, antibiotic therapy, antibiotic resistance, inhibitor-protected aminopenicillins. FOR CITATION: Zaitseva S.V., Zaitseva O.V., Lokshina E.E. Diagnosis and antibacterial treatment for community-acquired pneumonia in children during the COVID-19 pandemic. Russian Journal of Woman and Child Health. 2021;4(1):70–76. DOI: 10.32364/2618-8430- 2021-4-1-70-76.
doi:10.32364/2618-8430-2021-4-1-70-76 fatcat:gr7o6wq7sncw3oo5ynhj5mt6ge